+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton therapy for pediatric head and neck malignancies



Proton therapy for pediatric head and neck malignancies



Pediatric Blood and Cancer 65(2)



Pediatric head and neck malignancies are managed with intensive multimodality therapy. Proton beam therapy (PBT) may reduce toxicity by limiting exposure of normal tissue to radiation. In this study, we report acute toxicities and early outcomes following PBT for pediatric head and neck malignancies. Between 2010 and 2016, pediatric patients with nonhematologic malignancies of the head and neck were treated with PBT. Clinical and dosimetric data were abstracted from the medical record and treatment planning system with institutional review board approval. Sixty-nine consecutive pediatric patients were treated with proton-based radiotherapy for head and neck malignancies. Thirty-five were treated for rhabdomyosarcoma to a median dose of 50.4 Gy relative biological effectiveness [RBE]. Ten patients were treated for Ewing sarcoma to a median dose of 55.8 Gy[RBE]. Twenty-four patients were treated for other histologies to a median dose of 63.0 Gy[RBE]. Grade 3 oral mucositis, anorexia, and dysphagia were reported to be 4, 22, and 7%, respectively. Actuarial 1-year freedom from local recurrence was 92% (95% CI 80-97). Actuarial 1-year overall survival was 93% (95% CI 79-98) in the entire cohort. Oral cavity mucositis was significantly correlated with oral cavity dose (D80 and D50 [P < 0.05], where D80 and D50 are dose to 50% of the volume and dose to 80% of the volume, respectively). In this study, we report low rates of acute toxicity in a cohort of pediatric patients with head and neck malignancies. PBT appears safe for this patient population, with local control rates similar to historical reports. Longer follow-up will be required to evaluate late toxicity and long-term disease control.

(PDF emailed within 0-6 h: $19.90)

Accession: 060148735

Download citation: RISBibTeXText

PMID: 29058370

DOI: 10.1002/pbc.26858


Related references

Proton therapy for head and neck malignancies at Tsukuba. Strahlentherapie und Onkologie 180(2): 96-101, 2004

Proton beam radiation therapy for head and neck malignancies. Current Oncology Reports 12(3): 202-207, 2010

Proton Therapy in the USA From 2012 to 2014Increasing Treatment of Pediatric, Lung, Head and Neck, Gastrointestinal, and Breast Cancers, But No Increase in Prostate Cancer Treatments: A Study From the National Association for Proton Therapy. International Journal of Radiation Oncology*biology*physics 96(2): S136-S137, 2016

Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Medical Dosimetry 38(4): 390-394, 2014

Adaptive radiation therapy for pediatric head and neck malignancies: Dosimetric implications. Practical Radiation Oncology 5(2): E87-E94, 2015

Proton therapy for the treatment of pediatric head and neck cancers: A review. International Journal of Pediatric Otorhinolaryngology 79(12): 1995-2002, 2015

Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database. Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties 78(2): 61-69, 2017

Pediatric malignancies in the head and neck. Journal Of Japan Society For Cancer Therapy: 495, 1982

Pediatric Head and Neck Malignancies. Oral and Maxillofacial Surgery Clinics of North America 28(1): 11-19, 2016

Pediatric head and neck malignancies. Current Opinion in Otolaryngology and Head and Neck Surgery 17(6): 471-476, 2010

Pediatric malignancies presenting in the head and neck. International Journal of Pediatric Otorhinolaryngology 118: 36-41, 2018

Immediate free flap reconstruction for head and neck pediatric malignancies. Annals of Plastic Surgery 40(6): 594-599, 1998

Pediatric head and neck malignancies: US incidence and trends over 2 decades. Archives of Otolaryngology--Head and Neck Surgery 128(6): 655-659, 2002

Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. RadioTherapy and Oncology 121(3): 381-386, 2016

Pediatric head and neck malignancies: incidence and trends, 1973-2010. Otolaryngology--Head and Neck Surgery 152(6): 1127-1132, 2015